171 related articles for article (PubMed ID: 24618035)
21. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
22. Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
Gilling CE; Mittal AK; Chaturvedi NK; Iqbal J; Aoun P; Bierman PJ; Bociek RG; Weisenburger DD; Joshi SS
Br J Haematol; 2012 Jul; 158(2):216-231. PubMed ID: 22571278
[TBL] [Abstract][Full Text] [Related]
23. CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.
Girbl T; Hinterseer E; Grössinger EM; Asslaber D; Oberascher K; Weiss L; Hauser-Kronberger C; Neureiter D; Kerschbaum H; Naor D; Alon R; Greil R; Hartmann TN
Cancer Res; 2013 Jan; 73(2):561-70. PubMed ID: 23117883
[TBL] [Abstract][Full Text] [Related]
24. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
[TBL] [Abstract][Full Text] [Related]
25. Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.
Pemovska T; Johnson E; Kontro M; Repasky GA; Chen J; Wells P; Cronin CN; McTigue M; Kallioniemi O; Porkka K; Murray BW; Wennerberg K
Nature; 2015 Mar; 519(7541):102-5. PubMed ID: 25686603
[TBL] [Abstract][Full Text] [Related]
26. Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-mu and conditioned medium.
Steinberg J; Moore MA; Bernhardt B; Bona CA; Platsoucas CD
Scand J Immunol; 1987 Jun; 25(6):599-611. PubMed ID: 3110941
[TBL] [Abstract][Full Text] [Related]
27. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
[TBL] [Abstract][Full Text] [Related]
28. A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice.
Patten PEM; Ferrer G; Chen SS; Kolitz JE; Rai KR; Allen SL; Barrientos JC; Ioannou N; Ramsay AG; Chiorazzi N
Front Immunol; 2021; 12():627020. PubMed ID: 33767698
[TBL] [Abstract][Full Text] [Related]
29. Chronic Lymphocytic Leukemia: Disease Biology.
Koehrer S; Burger JA
Acta Haematol; 2024; 147(1):8-21. PubMed ID: 37717577
[TBL] [Abstract][Full Text] [Related]
30. Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.
Ali AY; Wu X; Eissa N; Hou S; Ghia JE; Murooka TT; Banerji V; Johnston JB; Lin F; Gibson SB; Marshall AJ
Leukemia; 2018 Sep; 32(9):1958-1969. PubMed ID: 29479062
[TBL] [Abstract][Full Text] [Related]
31. Integrin function in chronic lymphocytic leukemia.
Vincent AM; Cawley JC; Burthem J
Blood; 1996 Jun; 87(11):4780-8. PubMed ID: 8639849
[TBL] [Abstract][Full Text] [Related]
32. T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.
Vlachonikola E; Stamatopoulos K; Chatzidimitriou A
Front Immunol; 2020; 11():612244. PubMed ID: 33552073
[TBL] [Abstract][Full Text] [Related]
33. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia.
Consoli U; El-Tounsi I; Sandoval A; Snell V; Kleine HD; Brown W; Robinson JR; DiRaimondo F; Plunkett W; Andreeff M
Blood; 1998 Mar; 91(5):1742-8. PubMed ID: 9473241
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte migration and retention properties affected by ibrutinib in chronic lymphocytic leukemia.
Rey-Barroso J; Munaretto A; Rouquié N; Mougel A; Chassan M; Gadat S; Dewingle O; Poincloux R; Cadot S; Ysebaert L; Quillet-Mary A; Dupré L
Haematologica; 2024 Mar; 109(3):809-823. PubMed ID: 37381758
[TBL] [Abstract][Full Text] [Related]
35. The Nanomechanical Properties of CLL Cells Are Linked to the Actin Cytoskeleton and Are a Potential Target of BTK Inhibitors.
Sampietro M; Cassina V; Salerno D; Barbaglio F; Buglione E; Marrano CA; Campanile R; Scarfò L; Biedenweg D; Fregin B; Zamai M; Díaz Torres A; Labrador Cantarero V; Ghia P; Otto O; Mantegazza F; Caiolfa VR; Scielzo C
Hemasphere; 2023 Aug; 7(8):e931. PubMed ID: 37492437
[TBL] [Abstract][Full Text] [Related]
36. MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.
Crassini K; Shen Y; Stevenson WS; Christopherson R; Ward C; Mulligan SP; Best OG
Br J Haematol; 2018 Aug; 182(3):360-372. PubMed ID: 29767411
[TBL] [Abstract][Full Text] [Related]
37. The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.
Boudny M; Trbusek M
Klin Onkol; 2020; 33(1):32-38. PubMed ID: 32075387
[TBL] [Abstract][Full Text] [Related]
38. CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
Popek-Marciniec S; Zmorzyński S; Koczkodaj D; Marciniec M; Wąsik-Szczepanek E; Karczmarczyk A; Michalak-Wojnowska M; Filip A
Acta Haematol; 2023; 146(4):277-286. PubMed ID: 37015191
[TBL] [Abstract][Full Text] [Related]
39. Tumor-stroma interaction increases CD147 expression in neoplastic B lymphocytes in chronic lymphocytic leukemia.
Rodriguez CM; Gilardoni MB; Remedi MM; Sastre D; Heller V; Pellizas CG; Donadio AC
Blood Cells Mol Dis; 2020 May; 82():102405. PubMed ID: 32007924
[TBL] [Abstract][Full Text] [Related]
40. Growth and survival of B-chronic lymphocytic leukaemia cells.
Söderberg O
Med Oncol; 1998 Jul; 15(2):73-8. PubMed ID: 9789213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
